 |
|
|
| |
CLINIC-LEVEL FACTORS ASSOCIATED WITH TIME TO
VIRAL SUPPRESSION IN WASHINGTON DC
|
| |
| |
Reported by Jules Levin
CROI 2018
Monroe AK1, Rayeed N2, Jaurretche M1, Powers Happ L1, Trac K1, TerzianA1, Greenberg AE1, Castel AD1, on behalf of the DC Cohort Executive Committee
1 Milken Institute School of Public Health of the George Washington University, Washington, DC 2 Cerner Corporation, Kansas City, MO
|
| |
|
|
|
|
|
